UroGen Pharma Ltd. (URGN)
UroGen Pharma Max Pain By Strike
URGN trades at $19.74, 41.0% above the near-term max pain of $14 expiring Sep 19, 2025 (34 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($9-$6284.9), signaling increased put positioning or downside protection. Key magnetic zone at 15 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
UroGen Pharma Max Pain By Expiry
Max pain for URGN shows a downward trend from 6284.9 to 9, indicating bearish sentiment or hedging activity. The 884% spread signals divergent expectations across timeframes. Most levels below 19.74 may cap rallies. Strong magnetic level at 15 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
Expiration Date | Max Pain | Max Pain vs Current Price |
---|---|---|
Sep 19, 2025 | 14 | -5.74 (-29.08%) |
Oct 17, 2025 | 11 | -8.74 (-44.28%) |
Nov 21, 2025 | 10 | -9.74 (-49.34%) |
Dec 19, 2025 | 15 | -4.74 (-24.01%) |
Jan 16, 2026 | 9 | -10.74 (-54.41%) |
Feb 20, 2026 | 15 | -4.74 (-24.01%) |
Jun 18, 2026 | 15 | -4.74 (-24.01%) |
Aug 21, 2026 | 13 | -6.74 (-34.14%) |
Sep 23, 2064 | 6284.9 | 6265.16 (31738.40%) |